Abstract
Background
Staphylococcus aureus may be the most important wound pathogen and causative for most of surgical site infections. As many anti-staphylococcal drugs are useless because of resistance, novel antimicrobial strategies are strongly needed and may be provided by cold atmospheric plasma (CP), which is being currently investigated for antiseptic efficacy.
Methods
To test the antimicrobial properties of CP against Staphylococcus aureus, 168 methicillin-susceptible isolates (MSSA) and 50 methicillin-resistant isolates (MRSA) were treated with two technically different plasma sources [an atmospheric pressure plasma jet (APPJ) and a dielectric barrier discharge plasma (DBD)] in vitro.
Results
CP treatment allowed a reproducible and significant growth reduction of MRSA and MSSA. However, MRSA was significantly less susceptible to treatment with DBD than was MSSA, while no difference between MRSA and MSSA was found using APPJ.
Conclusions
As the initial physical antiseptic on skin, CP may be suitable for rapid decolonization of microbial pathogens in vivo. Each device must undergo validated efficacy testing prior to clinical application, as device related differences may occur.
Similar content being viewed by others
Notes
R Development Core Team (2009). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
References
Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest. 2003;111:1265–73.
U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. 2013;5–113.
Köck R, Schaumburg F, Mellmann A, et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS ONE. 2013;8:e55040.
Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–9.
Wijaya L, Hsu LY, Kurup A. Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation. Ann Acad Med Singapore. 2006;35:479–86.
Pasternack MS. Decontamination strategies for MRSA-colonized patients. Curr Infect Dis Rep. 2008;10:385–6.
Brehmer F, Haenssle HA, Daeschlein G, et al. Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): results of a monocentric, two-armed, open, prospective, randomized, and controlled trial (NCT01415622). J Eur Acad Dermatol Venereol. 2014. doi:10.1111/jdv.12490.
Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163:78–82.
Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167:404–10.
Brandenburg R, Ehlbeck J, Stieber M, et al. Antimicrobial treatment of heat sensitive materials by means of atmospheric pressure Rf-driven plasma jet. Contrib Plasma Phys. 2007;47:72–9.
Fridman G, Brooks AD, Balasubramanian M, et al. Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria. Plasma Process Polym. 2007;4:370–5.
Daeschlein G, von Woedtke T, Kindel E, et al. Antibacterial activity of an atmospheric pressure plasma jet against relevant wound pathogens in vitro on a simulated wound environment. Plasma Process Polym. 2010;7:224–30.
Daeschlein G, Scholz S, von Woedtke T, et al. In vitro killing of clinical fungal strains by low-temperature atmospheric-pressure plasma jet. IEEE Trans Plasma Sci. 2011;39:815–21.
Daeschlein G, Napp M, von Podewils S, et al. In vitro susceptibility of multidrug resistant skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2014;11:175–83.
Fridman G, Friedman G, Gutsol A, et al. Applied plasma medicine. Plasma Process Polym. 2008;5:503–33.
Shashurin A, Keidar M, Bronnikov S, et al. Living tissue under treatment of cold plasma atmospheric jet. Appl Phys Lett. 2008;93:181501.
Kalghatgi SU, Fridman G, Fridman A, et al. Non-thermal dielectric barrier discharge plasma treatment of endothelial cells. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3578–81.
Daeschlein G, Darm K, Majunke S, et al. In vivo monitoring of atmospheric pressure plasma jet (APPJ) skin therapy by confocal laserscan microscopy (CLSM). In: Paper presented at the second international conference on plasma medicine, San Antonio, TX, 2009.
Lademann J, Richter H, Alborova A, et al. Risk assessment of the application of a plasma jet in dermatology. J Biomed Opt. 2009;14:054025.
Lademann O, Richter H, Patzelt A, et al. Application of a plasma-jet for skin antisepsis: analysis of the thermal action of the plasma by laser scanning microscopy. Laser Phys Lett. 2010;7:458–62.
Daeschlein G, Scholz S, Ahmed R, et al. Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture. J Dtsch Dermatol Ges. 2012;10:509–15.
Heinlin J, Morfill G, Landthaler M, et al. Plasma medicine: possible applications in dermatology. J Dtsch Dermatol Ges. 2010;8:968–76.
O’Connor N, Cahill O, Daniels S, et al. Cold atmospheric pressure plasma and decontamination. Can it contribute to preventing hospital-acquired infections? J Hosp Infect. 2014;88:59–65.
Mai-Prochnow A, Murphy AB, McLean KM, et al. Atmospheric pressure plasmas: infection control and bacterial responses. Int J Antimicrob Agents. 2014;43:508–17.
Bowler PG, Davies BJ. The microbiology of infected and noninfected leg ulcers. Int J Dermatol. 1999;38:573–8.
Meyer V, Kerk N, Mellmann A, et al. MRSA eradication in dermatologic outpatients—theory and practice. J Dtsch Dermatol Ges. 2012;10:186–96.
Jockenhöfer F, Gollnick H, Herberger K, et al. Bacteriological pathogen spectrum of chronic leg ulcers: results of a multicenter trial in dermatologic wound care centers differentiated by regions. J Dtsch Dermatol Ges. 2013;11:1057–63.
Ulmer M, Lademann J, Patzelt A, et al. New strategies for preoperative skin antisepsis. Skin Pharmacol Physiol. 2014;27:283–92.
Maisch T, Shimizu T, Li YF, et al. Decolonisation of MRSA, S. aureus and E. coli by cold-atmospheric plasma using a porcine skin model in vitro. PLoS ONE. 2012;7:e34610.
Weltmann KD, Kindel E, Brandenburg R, et al. Atmospheric pressure plasma jet for medical therapy: plasma parameters and risk estimation. Contrib Plasma Phys. 2009;49:631–40.
Kuchenbecker M, Bibinov N, Kaemling A, et al. Characterization of DBD plasma source for biomedical applications. J Phys D Appl Phys. 2009;42:045212.
Helmke A, Hoffmeister D, Mertens N, et al. The acidification of lipid film surfaces by non-thermal DBD at atmospheric pressure in air. New J Phys. 2009;11:115025.
Thomas L, Maillard JY, Lambert RJ, Russell AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a “residual” concentration. J Hosp Infect. 2000;46:297–303.
Kawai M, Yamada S, Ishidoshiro A, et al. Cell-wall thickness: possible mechanism of acriflavine resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2009;58:331–6.
Daeschlein G, Scholz S, Arnold A, et al. In vitro susceptibility of important skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2012;9:380–9.
Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Rep Reg. 2013;21:800–7.
Acknowledgments
This study was performed within the joint research project “Campus PlasmaMed”, supported by the German Federal Ministry of Education and Research (Grant no. 13N9773 and 13N9779). We thank Prof. Wolfgang Witte and PD Guido Werner for confirmation of laMRSA and caMRSA at the National Reference Center for Staphylococci in Wernigerode, Germany.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors and co-authors deny any potential conflict of interest (e.g., employment, consulting fees, research contracts, stock ownership, patent licenses, honoraria, advisory affiliations, etc.).
Additional information
Matthias Napp and Georg Daeschlein have equally contributed to this work.
Rights and permissions
About this article
Cite this article
Napp, M., Daeschlein, G., von Podewils, S. et al. In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources. Infection 44, 531–537 (2016). https://doi.org/10.1007/s15010-016-0888-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-016-0888-9